These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1578934)

  • 1. Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.
    Stryckmans P; De Witte T; Marie JP; Fillet G; Peetermans M; Bury J; Muus P; Andrien JM; Hayat M; Jaksic B
    Leukemia; 1992; 6 Suppl 2():199-203. PubMed ID: 1578934
    [No Abstract]   [Full Text] [Related]  

  • 2. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
    Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
    Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
    Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
    Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
    [No Abstract]   [Full Text] [Related]  

  • 4. Adult acute leukemia.
    Hoelzer D; Büchner T; Gale RP; Zittoun R
    Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of acute lymphoblastic leukemia in adults.
    Hoelzer D
    Leukemia; 1992; 6 Suppl 2():132-5. PubMed ID: 1578915
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic BMT versus autologous BMT in childhood acute lymphoblastic leukemia (ALL): an Italian cooperative study of vincristine (VCR), F-TBI and cyclophosphamide. AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) Italy.
    Uderzo C; Coleselli P; Messina C; Dini G; Bonetti F; Andolina M; Bagnulo S; Miniero R; Rondelli R; Paolucci P
    Bone Marrow Transplant; 1991; 7 Suppl 2():132. PubMed ID: 1878677
    [No Abstract]   [Full Text] [Related]  

  • 7. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM
    Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
    Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
    Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
    Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.
    Arlin ZA; Feldman EJ; Finger L; Ahmed T; Mittelman A; Puccio C; Cook P; Chun HG
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):44-7. PubMed ID: 1780752
    [No Abstract]   [Full Text] [Related]  

  • 13. The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group.
    Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
    Leukemia; 1992; 6 Suppl 2():175-7. PubMed ID: 1578926
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy versus allogeneic or autologous bone marrow transplantation in second complete remission of acute lymphoblastic leukemia.
    Herve P; Bordigoni P; Plouvier E
    Leukemia; 1992 Nov; 6 Suppl 4():59-61. PubMed ID: 1434835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].
    Zittoun R; Rio B; Delmer A; Vekhof A; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):15-6. PubMed ID: 8511034
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 17. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous bone marrow transplantation in acute lymphoblastic leukemia: biological and clinical aspects.
    Carella AM
    Haematologica; 1990; 75(1):79-83. PubMed ID: 2186984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
    Cassileth PA; Andersen JW; Bennett JM; Harrington DP; Hines JD; Lazarus HM; Mazza JJ; McGlave PP; O'Connell MJ; Paietta E
    Leukemia; 1992; 6 Suppl 2():116-9. PubMed ID: 1578910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.